STAT Plus: Italy becomes first country to require pharma to disclose public funding for R&D costs
Amid growing clamor for more transparency from the pharmaceutical industry, Italy has become the first country to require drug makers to disclose data about public funding for any of their medicines during negotiations over pricing and reimbursement.
As a result, the Italian Medicines Agency, known as AIFA, will have insight into various costs, such as R&D and marketing, that drug companies incur, as well as data on revenue, patents, and prices offered to other countries, according to a decree published last week. The decree is notable, in part, because Italy is a Group of Seven country with a significant market for the global pharmaceutical industry.
Continue to STAT Plus to read the full story…
